Advertisement

Topics

BridgeBio Bags $135M For “Hub and Spoke” Rare Disease Drug R&D

12:15 EDT 13 Sep 2017 | Xconomy

Thousands of diseases have been traced to genetic origins, but the vast majority have no treatment at all. BridgeBio wants to reduce that unmet need with an unusual model for developing drugs to treat rare genetic diseases, and it now has $135 million in new funding. Palo Alto, CA-based BridgeBio says new investor Viking Global […]

Original Article: BridgeBio Bags $135M For “Hub and Spoke” Rare Disease Drug R&D

NEXT ARTICLE

More From BioPortfolio on "BridgeBio Bags $135M For “Hub and Spoke” Rare Disease Drug R&D"

Quick Search
Advertisement